Editas Medicine, Inc. Annual Nonoperating Income (Expense) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Editas Medicine, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • Editas Medicine, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $3.53M, a 31.5% decline year-over-year.
  • Editas Medicine, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $18M, a 32.2% increase year-over-year.
  • Editas Medicine, Inc. annual Nonoperating Income (Expense) for 2023 was $16M, a 189% increase from 2022.
  • Editas Medicine, Inc. annual Nonoperating Income (Expense) for 2022 was $5.52M, a 757% increase from 2021.
  • Editas Medicine, Inc. annual Nonoperating Income (Expense) for 2021 was $644K, a 96.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16M +$10.4M +189% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $5.52M +$4.87M +757% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $644K -$18.2M -96.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $18.9M +$11.7M +163% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $7.18M +$3.4M +90.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $3.77M +$4.16M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$391K -$396K -7920% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 $5K +$37.6M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$37.6M -$36.6M -3807% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 -$962K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.